The use of senna with docusate for postoperative constipation after pelvic reconstructive surgery: a randomized, double-blind, placebo-controlled trial

ScienceDirect - Gynecologic Oncology : The molecular genetic basis of ovarian cancer and its roadmap towards a better treatment

Note: subscription required )$$$)

The molecular genetic basis of ovarian cancer and its roadmap towards a better treatment

Social Science & Medicine : Scripting patienthood with patient clothing

Re: judging based on clothing/dress

Medicines & Drugs | Information leaflets on specific medicines and drugs | Patient UK

Australia: Consumer medicine information

Health Canada Drug Product Database (DPD)

Drug Information Portal - U.S. National Library of Medicine - Quick Access to Quality Drug Information (searchable)

The Peninsula On-line: Qatar's (English) Women cancer patients face family turmoil

Note: (from Wiki) Qatar, also known as the State of Qatar or locally Dawlat Qaṭar, is an Arab emirate in the Middle East, occupying the small Qatar Peninsula on the northeasterly coast of the larger Arabian Peninsula. It is bordered by Saudi Arabia to the south; otherwise the Persian Gulf surrounds the state. A strait of the Persian Gulf separates Qatar from the relatively nearby island nation of Bahrain. “Every woman is at risk for developing a gynaecologic cancer,” said Dr Jeremie Arash Rafii Tabrizi, assistant professor of genetic medicine in obstetrics and gynecology at WCMC-Q. “This year, over 78,000 women in the United States will be diagnosed, and over 28,000 will die from gynecologic cancer — and the numbers, percentage-wise, are similar in the Middle East,” he said at a lecture on Women and Cancer as a part of the WCMC-Q’s Medicine and U lecture series, recently.

“The perception of cancer is different in each society. In the Middle East in particular, the diagnosis of any cancer is associated with a high level of anxiety—and it is often viewed as having a shameful disease. The loss of fertility related to cancer treatment also can have a significant impact on women and their families.”

CureToday.com: Spring 2010 Article - "Special Report" Mammogram issue/controversies

Medical News: SGO: Drug Combination Slows Recurrent Ovarian Cancer - Taxotere + Carboplatin

"Median PFS was almost 14 months with combination therapy, while sequential administration of docetaxel (Taxotere) and carboplatin was associated with a median PFS of about eight months."

NEJM -- Performance of Common Genetic Variants in Breast-Cancer Risk Models

Note: full text is pay-per-view
Conclusions The inclusion of newly discovered genetic factors modestly improved the performance of risk models for breast cancer. The level of predicted breast-cancer risk among most women changed little after the addition of currently available genetic information.